To bring the COVID-19 Vaccine Moderna to the Philippines and other Southeast Asian countries, last April 2021, Zuellig Pharma announced a partnership with Moderna Inc., a biotechnology company ...

5 February 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that it has completed the acquisition of two brands, Cialis® (Tadalafil) and Alimta® (Pemetrexed ...

Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...

Sybos Holdings, a unit of Zuellig Group, said it had entered into a block trade agreement with a financial institution to ...

BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounja ...

John Graham, Group CEO of Zuellig Pharma, shares how big pharmaceutical companies are taking steps to mitigate the fallout from new U.S. tariffs. RFK Jr. Calls Out King Abdullah: ‘They’ve Cut ...

New agreement marks major milestone for Zuellig Pharma as it focuses on expanding its consumer healthcare segment, and for Institut AllergoSan as it expands its global presence SINGAPORE - Media ...

UBS launched a $NZ950 million ($880 million) block trade in EBOS Group after-market on Wednesday on behalf of major ...

BANGKOK, THAILAND – Media OutReach Newswire – 27 May 2025 – Zuellig Pharma, a leading healthcare solutions company in Asia, ...

Zuellig Pharma introduces Eli Lilly’s innovative obesity and diabetes medicine, Mounjaro in Thailand: Bangkok, Thailand Thursday, May 29, 2025, 11:00 Hrs [IST] Zuellig Pharma, a ...

Zuellig Pharma, a leading healthcare solutions company in Asia, announced that it has signed a 10-year commercialisation partnership with Austria-based Institut AllergoSan, a research and development ...

(MENAFN- Dubai PR Network) Mounjaro (tirzepatide) will be available in the market from the end of May 2025 BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading ...